“Empagliflozin-Induced Acute Pancreatitis and Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes Mellitus”. American Journal of Chemistry and Pharmacy 1, no. 2 (October 23, 2022): 1–4. Accessed June 4, 2026. https://e-pallipublishers.com/index.php/ajcp/article/view/747.